VS

Vanguri Srujan Rayal

Active Director Director DIN 11509391
DIN 11509391 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vanguri Srujan Rayal

Data last updated:

Vanguri Srujan Rayal is a Director at Samven Pharmaceutical Private Limited (since 2026). The company operates in Pharma.

DIN 11509391
Primary Designation Director
Industry Pharma
First Appointment 28 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jan 20262026Active

Board colleagues of Vanguri Srujan Rayal

NameDINCompanyDesignation
Samatha Vanguri09131091Samven Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Samven Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Vanguri Srujan Rayal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vanguri Srujan Rayal

Vanguri Srujan Rayal currently holds 1 directorship: Samven Pharmaceutical Private Limited (Director, since 28 Jan 2026).

Vanguri Srujan Rayal was first appointed on 28 Jan 2026 as Director at Samven Pharmaceutical Private Limited.

The current boards of Vanguri Srujan Rayal's companies include Samatha Vanguri (Samven Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available